These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 18793625)
1. Urine acylcarnitine analysis by ESI-MS/MS: a new tool for the diagnosis of peroxisomal biogenesis disorders. Duranti G; Boenzi S; Rizzo C; Ravà L; Di Ciommo V; Carrozzo R; Meschini MC; Johnson DW; Dionisi-Vici C Clin Chim Acta; 2008 Dec; 398(1-2):86-9. PubMed ID: 18793625 [TBL] [Abstract][Full Text] [Related]
2. Characteristic acylcarnitine profiles in inherited defects of peroxisome biogenesis: a novel tool for screening diagnosis using tandem mass spectrometry. Rizzo C; Boenzi S; Wanders RJ; Duran M; Caruso U; Dionisi-Vici C Pediatr Res; 2003 Jun; 53(6):1013-8. PubMed ID: 12646728 [TBL] [Abstract][Full Text] [Related]
3. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Maeda Y; Ito T; Suzuki A; Kurono Y; Ueta A; Yokoi K; Sumi S; Togari H; Sugiyama N Rapid Commun Mass Spectrom; 2007; 21(5):799-806. PubMed ID: 17279485 [TBL] [Abstract][Full Text] [Related]
5. Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency. Maeda Y; Ito T; Ohmi H; Yokoi K; Nakajima Y; Ueta A; Kurono Y; Togari H; Sugiyama N J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):154-9. PubMed ID: 18088573 [TBL] [Abstract][Full Text] [Related]
6. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization. Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563 [TBL] [Abstract][Full Text] [Related]
7. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry. Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290 [TBL] [Abstract][Full Text] [Related]
8. Determination of urinary acylcarnitines by ESI-MS coupled with solid-phase microextraction (SPME). Möder M; Löster H; Herzschuh R; Popp P J Mass Spectrom; 1997 Nov; 32(11):1195-204. PubMed ID: 9373960 [TBL] [Abstract][Full Text] [Related]
9. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS). Yousef IM; Perwaiz S; Lamireau T; Tuchweber B Med Sci Monit; 2003 Mar; 9(3):MT21-31. PubMed ID: 12640349 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry: a second-tier method with improved specificity and sensitivity. Chalcraft KR; Britz-McKibbin P Anal Chem; 2009 Jan; 81(1):307-14. PubMed ID: 19117458 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS. Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091 [TBL] [Abstract][Full Text] [Related]
12. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects. Fuda F; Narayan SB; Squires RH; Bennett MJ Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039 [TBL] [Abstract][Full Text] [Related]
13. Dicarboxylic acylcarnitine biomarkers in peroxisome biogenesis disorders. Wangler MF; Lesko B; Dahal R; Jangam S; Bhadane P; Wilson TE; McPheron M; Miller MJ Mol Genet Metab; 2023 Nov; 140(3):107680. PubMed ID: 37567036 [TBL] [Abstract][Full Text] [Related]
14. Rapid measurement of plasma acylcarnitines by liquid chromatography-tandem mass spectrometry without derivatization. Ghoshal AK; Guo T; Soukhova N; Soldin SJ Clin Chim Acta; 2005 Aug; 358(1-2):104-12. PubMed ID: 16018880 [TBL] [Abstract][Full Text] [Related]
15. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002 [TBL] [Abstract][Full Text] [Related]
16. cis-3,4-Methylene-heptanoylcarnitine: characterization and verification of the C8:1 acylcarnitine in human urine. Yang S; Minkler P; Hoppel C J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):251-8. PubMed ID: 17692580 [TBL] [Abstract][Full Text] [Related]
17. Precursor ion scan profiles of acylcarnitines by atmospheric pressure thermal desorption chemical ionization tandem mass spectrometry. Paglia G; D'Apolito O; Corso G Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3809-15. PubMed ID: 18980266 [TBL] [Abstract][Full Text] [Related]
18. MRI as diagnostic tool in early-onset peroxisomal disorders. van der Knaap MS; Wassmer E; Wolf NI; Ferreira P; Topçu M; Wanders RJ; Waterham HR; Ferdinandusse S Neurology; 2012 Apr; 78(17):1304-8. PubMed ID: 22459681 [TBL] [Abstract][Full Text] [Related]
19. Peroxisomal disorders: clinical and biochemical studies in 15 children and prenatal diagnosis in 7 families. Steinberg SJ; Elçioglu N; Slade CM; Sankaralingam A; Dennis N; Mohammed SN; Fensom AH Am J Med Genet; 1999 Aug; 85(5):502-10. PubMed ID: 10405451 [TBL] [Abstract][Full Text] [Related]
20. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Reuter SE; Evans AM; Faull RJ; Chace DH; Fornasini G Ann Clin Biochem; 2005 Sep; 42(Pt 5):387-93. PubMed ID: 16168195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]